These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20832295)

  • 21. [C-reactive protein potential risk factor for cardiovascular disease].
    Tornvall P; Pernow J; Hansson LO
    Lakartidningen; 2003 Aug; 100(35):2691-3. PubMed ID: 14531129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.
    Haffner SM
    Am J Cardiol; 2006 Jan; 97(2A):3A-11A. PubMed ID: 16442931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein is an essential aspect of cardiovascular risk factor stratification.
    Yeh ET
    Can J Cardiol; 2004 Aug; 20 Suppl B():93B-96B. PubMed ID: 15309212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk in long-term survivors of testicular cancer.
    Vaughn DJ; Palmer SC; Carver JR; Jacobs LA; Mohler ER
    Cancer; 2008 May; 112(9):1949-53. PubMed ID: 18338810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
    Best LG; Zhang Y; Lee ET; Yeh JL; Cowan L; Palmieri V; Roman M; Devereux RB; Fabsitz RR; Tracy RP; Robbins D; Davidson M; Ahmed A; Howard BV
    Circulation; 2005 Aug; 112(9):1289-95. PubMed ID: 16116058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
    Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
    BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein and dietary nutrients in urban Asian Indian adolescents and young adults.
    Arya S; Isharwal S; Misra A; Pandey RM; Rastogi K; Vikram NK; Dhingra V; Chatterjee A; Sharma R; Luthra K
    Nutrition; 2006 Sep; 22(9):865-71. PubMed ID: 16829027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Martin BS; Mackey JR
    Brain Behav Immun; 2005 Sep; 19(5):381-8. PubMed ID: 15922556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Objective and subjective predictors of cancer-related stress symptoms in testicular cancer survivors.
    Fleer J; Sleijfer D; Hoekstra H; Tuinman M; Klip E; Hoekstra-Weebers J
    Patient Educ Couns; 2006 Dec; 64(1-3):142-50. PubMed ID: 16480847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [C-reactive protein: cardiovascular issues of an acute-phase protein].
    Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
    Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does C-reactive protein represent an oxidative stress marker in cardiovascular disease?
    Korantzopoulos P; Papaioannides D; Galaris D; Kokkoris S
    Int J Clin Pract; 2003 Apr; 57(3):252. PubMed ID: 12723737
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein and the risk of cancer: a mendelian randomization study.
    Allin KH; Nordestgaard BG; Zacho J; Tybjaerg-Hansen A; Bojesen SE
    J Natl Cancer Inst; 2010 Feb; 102(3):202-6. PubMed ID: 20056955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?].
    Yosef-Levi IM; Grad E; Danenberg HD
    Harefuah; 2007 Dec; 146(12):970-4, 996. PubMed ID: 18254451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testicular cancer patients: considerations in long-term follow-up.
    Gospodarowicz M
    Hematol Oncol Clin North Am; 2008 Apr; 22(2):245-55, vi. PubMed ID: 18395148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein and risk of breast cancer.
    Zhang SM; Lin J; Cook NR; Lee IM; Manson JE; Buring JE; Ridker PM
    J Natl Cancer Inst; 2007 Jun; 99(11):890-4. PubMed ID: 17551149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?
    Toriola AT; Ulrich CM
    Future Oncol; 2011 Oct; 7(10):1125-8. PubMed ID: 21992725
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer.
    Wethal T; Kjekshus J; Røislien J; Ueland T; Andreassen AK; Wergeland R; Aukrust P; Fosså SD
    J Cancer Surviv; 2007 Mar; 1(1):8-16. PubMed ID: 18648940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.